Eicosapentaenoic Acid and the Outcomes in Older Patients Undergoing Atrial Fibrillation Ablation.
Yuya SudoTakeshi MorimotoRyu TsushimaAkihiro OkaMasahiro SogoMasatomo OzakiMasahiko TakahashiKeisuke OkawaPublished in: Journal of the American Heart Association (2024)
The EPA/AA was associated with AF recurrence and MACE after ablation in patients with AF aged ≥65 years.
Keyphrases